• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

沙芬酰胺是一种单胺氧化酶抑制剂,可调节钠离子电流的幅度、门控和滞后。

Safinamide, an inhibitor of monoamine oxidase, modulates the magnitude, gating, and hysteresis of sodium ion current.

机构信息

Department of Pediatrics, Chi-Mei Medical Center, Tainan, Taiwan.

Department of Physiology, National Cheng Kung University Medical College, Tainan, Taiwan.

出版信息

BMC Pharmacol Toxicol. 2024 Feb 8;25(1):17. doi: 10.1186/s40360-024-00739-5.

DOI:10.1186/s40360-024-00739-5
PMID:38331833
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10851555/
Abstract

BACKGROUND

Safinamide (SAF), an α-aminoamide derivative and a selective, reversible monoamine oxidase (MAO)-B inhibitor, has both dopaminergic and nondopaminergic (glutamatergic) properties. Several studies have explored the potential of SAF against various neurological disorders; however, to what extent SAF modulates the magnitude, gating, and voltage-dependent hysteresis [Hys] of ionic currents remains unknown.

METHODS

With the aid of patch-clamp technology, we investigated the effects of SAF on voltage-gated sodium ion (Na) channels in pituitary GH3 cells.

RESULTS

SAF concentration-dependently stimulated the transient (peak) and late (sustained) components of voltage-gated sodium ion current (I) in pituitary GH cells. The conductance-voltage relationship of transient I [I] was shifted to more negative potentials with the SAF presence; however, the steady-state inactivation curve of I was shifted in a rightward direction in its existence. SAF increased the decaying time constant of I induced by a train of depolarizing stimuli. Notably, subsequent addition of ranolazine or mirogabalin reversed the SAF-induced increase in the decaying time constant. SAF also increased the magnitude of window I induced by an ascending ramp voltage V. Furthermore, SAF enhanced the Hys behavior of persistent I induced by an upright isosceles-triangular V. Single-channel cell-attached recordings indicated SAF effectively increased the open-state probability of Na channels. Molecular docking revealed SAF interacts with both MAO and Na channels.

CONCLUSION

SAF may interact directly with Na channels in pituitary neuroendocrine cells, modulating membrane excitability.

摘要

背景

沙芬酰胺(SAF)是一种 α-氨基酰胺衍生物,也是一种选择性、可逆的单胺氧化酶(MAO)-B 抑制剂,具有多巴胺能和非多巴胺能(谷氨酸能)特性。几项研究探索了 SAF 对各种神经疾病的潜在作用;然而,SAF 调节离子电流幅度、门控和电压依赖性滞后 [Hys] 的程度仍不清楚。

方法

借助膜片钳技术,我们研究了 SAF 对垂体 GH3 细胞中电压门控钠离子(Na)通道的影响。

结果

SAF 浓度依赖性地刺激了垂体 GH 细胞中电压门控钠离子电流(I)的瞬态(峰值)和晚期(持续)成分。SAF 存在时,瞬态 I [I]的电导-电压关系向更负的电位移动;然而,I 的稳态失活曲线在其存在下向右侧移动。SAF 增加了由去极化刺激串引起的 I 的衰减时间常数。值得注意的是,随后加入雷诺嗪或米罗加巴林可逆转 SAF 诱导的衰减时间常数增加。SAF 还增加了上升斜坡电压 V 诱导的窗口 I 的幅度。此外,SAF 增强了直立等腰三角形 V 诱导的持续 I 的 Hys 行为。单通道细胞附着记录表明 SAF 有效增加了 Na 通道的开放状态概率。分子对接显示 SAF 与 MAO 和 Na 通道都相互作用。

结论

SAF 可能直接与垂体神经内分泌细胞中的 Na 通道相互作用,调节膜兴奋性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd4b/10851555/cd6f99552749/40360_2024_739_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd4b/10851555/fed9389f642c/40360_2024_739_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd4b/10851555/98695e8f06b3/40360_2024_739_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd4b/10851555/5d157ccdc4f3/40360_2024_739_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd4b/10851555/705770d8eead/40360_2024_739_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd4b/10851555/31700a55a85e/40360_2024_739_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd4b/10851555/344647500570/40360_2024_739_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd4b/10851555/c4da26aec147/40360_2024_739_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd4b/10851555/d035b65794bb/40360_2024_739_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd4b/10851555/a82d5cc1c9dc/40360_2024_739_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd4b/10851555/cae91358a2fe/40360_2024_739_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd4b/10851555/cd6f99552749/40360_2024_739_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd4b/10851555/fed9389f642c/40360_2024_739_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd4b/10851555/98695e8f06b3/40360_2024_739_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd4b/10851555/5d157ccdc4f3/40360_2024_739_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd4b/10851555/705770d8eead/40360_2024_739_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd4b/10851555/31700a55a85e/40360_2024_739_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd4b/10851555/344647500570/40360_2024_739_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd4b/10851555/c4da26aec147/40360_2024_739_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd4b/10851555/d035b65794bb/40360_2024_739_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd4b/10851555/a82d5cc1c9dc/40360_2024_739_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd4b/10851555/cae91358a2fe/40360_2024_739_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd4b/10851555/cd6f99552749/40360_2024_739_Fig11_HTML.jpg

相似文献

1
Safinamide, an inhibitor of monoamine oxidase, modulates the magnitude, gating, and hysteresis of sodium ion current.沙芬酰胺是一种单胺氧化酶抑制剂,可调节钠离子电流的幅度、门控和滞后。
BMC Pharmacol Toxicol. 2024 Feb 8;25(1):17. doi: 10.1186/s40360-024-00739-5.
2
The Evidence for Effective Inhibition of Produced by Mirogabalin ((1R,5S,6S)-6-(aminomethyl)-3-ethyl-bicyclo [3.2.0] hept-3-ene-6-acetic acid), a Known Blocker of Ca Channels.米拉巴仑((1R,5S,6S)-6-(氨甲基)-3-乙基-双环[3.2.0]庚-3-烯-6-乙酸)抑制产生的有效证据,米拉巴仑是已知的钙通道阻滞剂。
Int J Mol Sci. 2022 Mar 31;23(7):3845. doi: 10.3390/ijms23073845.
3
Characterization in Inhibitory Effectiveness of Carbamazepine in Voltage-Gated Na and Erg-Mediated K Currents in a Mouse Neural Crest-Derived (Neuro-2a) Cell Line.研究卡马西平对电压门控钠离子通道和erg 介导的钾电流的抑制作用及其机制。
Int J Mol Sci. 2022 Jul 17;23(14):7892. doi: 10.3390/ijms23147892.
4
Chimeric agents derived from the functionalized amino acid, lacosamide, and the α-aminoamide, safinamide: evaluation of their inhibitory actions on voltage-gated sodium channels, and antiseizure and antinociception activities and comparison with lacosamide and safinamide.源自功能化氨基酸拉科酰胺和α-氨基酰胺沙芬酰胺的嵌合剂:评估它们对电压门控钠通道的抑制作用、抗癫痫和抗伤害感受活性,并与拉科酰胺和沙芬酰胺进行比较。
ACS Chem Neurosci. 2015 Feb 18;6(2):316-30. doi: 10.1021/cn5002182. Epub 2014 Dec 9.
5
Effective Accentuation of Voltage-Gated Sodium Current Caused by Apocynin (4'-Hydroxy-3'-methoxyacetophenone), a Known NADPH-Oxidase Inhibitor.已知的NADPH氧化酶抑制剂鱼藤酮(4'-羟基-3'-甲氧基苯乙酮)对电压门控钠电流的有效增强作用。
Biomedicines. 2021 Sep 3;9(9):1146. doi: 10.3390/biomedicines9091146.
6
Characterization in Effective Stimulation on the Magnitude, Gating, Frequency Dependence, and Hysteresis of Exerted by Picaridin (or Icaridin), a Known Insect Repellent.对驱避剂派卡瑞丁(或埃卡瑞丁)的效力、门控、频率依赖性和滞后性的有效刺激的特征。
Int J Mol Sci. 2022 Aug 26;23(17):9696. doi: 10.3390/ijms23179696.
7
Concerted suppressive effects of carisbamate, an anti-epileptic alkyl-carbamate drug, on voltage-gated Na and hyperpolarization-activated cation currents.抗癫痫烷基氨基甲酸酯类药物卡立普多对电压门控性钠电流和超极化激活阳离子电流的协同抑制作用。
Front Cell Neurosci. 2023 May 24;17:1159067. doi: 10.3389/fncel.2023.1159067. eCollection 2023.
8
Effective Perturbations by Small-Molecule Modulators on Voltage-Dependent Hysteresis of Transmembrane Ionic Currents.小分子调节剂对跨膜离子电流电压依赖性滞后的有效扰动。
Int J Mol Sci. 2022 Aug 21;23(16):9453. doi: 10.3390/ijms23169453.
9
Inhibition of Voltage-Gated Na Currents Exerted by KB-R7943 (2-[2-[4-(4-nitrobenzyloxy)phenyl]ethyl]isothiourea), an Inhibitor of Na-Ca Exchanging Process.电压门控钠电流的抑制作用由 KB-R7943(2-[2-[4-(4-硝基苯甲氧基)苯基]乙基]异硫脲)产生,它是一种钠钙交换过程的抑制剂。
Int J Mol Sci. 2023 Jan 16;24(2):1805. doi: 10.3390/ijms24021805.
10
Different role of TTX-sensitive voltage-gated sodium channel (Na 1) subtypes in action potential initiation and conduction in vagal airway nociceptors.不同型 TTX 敏感型电压门控钠离子通道(Na 1)亚型在迷走气道伤害感受器动作电位起始和传导中的作用。
J Physiol. 2018 Apr 15;596(8):1419-1432. doi: 10.1113/JP275698.

引用本文的文献

1
Development of Novel Alaninamide Derivatives with Anticonvulsant Activity and Favorable Safety Profiles in Animal Models.新型丙氨酰胺衍生物的开发具有抗惊厥活性和良好的动物模型安全性特征。
Int J Mol Sci. 2024 Sep 12;25(18):9861. doi: 10.3390/ijms25189861.

本文引用的文献

1
New salts of teriflunomide (TFM) - Single crystal X-ray and solid state NMR investigation.特立氟胺(TFM)的新盐——单晶X射线和固态核磁共振研究。
Solid State Nucl Magn Reson. 2022 Dec;122:101820. doi: 10.1016/j.ssnmr.2022.101820. Epub 2022 Aug 27.
2
Endogenous ion channels expressed in human embryonic kidney (HEK-293) cells.内源性离子通道表达于人胚肾(HEK-293)细胞中。
Pflugers Arch. 2022 Jul;474(7):665-680. doi: 10.1007/s00424-022-02700-z. Epub 2022 May 14.
3
The Evidence for Effective Inhibition of Produced by Mirogabalin ((1R,5S,6S)-6-(aminomethyl)-3-ethyl-bicyclo [3.2.0] hept-3-ene-6-acetic acid), a Known Blocker of Ca Channels.
米拉巴仑((1R,5S,6S)-6-(氨甲基)-3-乙基-双环[3.2.0]庚-3-烯-6-乙酸)抑制产生的有效证据,米拉巴仑是已知的钙通道阻滞剂。
Int J Mol Sci. 2022 Mar 31;23(7):3845. doi: 10.3390/ijms23073845.
4
Efficacy and safety of high doses of safinamide in advanced Parkinson disease.高剂量沙芬酰胺治疗晚期帕金森病的疗效与安全性
Parkinsonism Relat Disord. 2022 Apr;97:73-74. doi: 10.1016/j.parkreldis.2022.03.010. Epub 2022 Mar 23.
5
Activation of Voltage-Gated Na Current by GV-58, a Known Activator of Ca Channels.已知的钙通道激活剂GV-58对电压门控钠电流的激活作用。
Biomedicines. 2022 Mar 20;10(3):721. doi: 10.3390/biomedicines10030721.
6
The Effects of Safinamide Adjunct Therapy on Depression and Apathy in Patients With Parkinson's Disease: Analysis of a Japanese Phase 2/3 Study.沙芬酰胺辅助治疗对帕金森病患者抑郁和冷漠的影响:一项日本2/3期研究的分析
Front Neurol. 2022 Feb 7;12:752632. doi: 10.3389/fneur.2021.752632. eCollection 2021.
7
Safinamide in the treatment pathway of Parkinson's Disease: a European Delphi Consensus.沙芬酰胺在帕金森病治疗路径中的应用:一项欧洲德尔菲共识。
NPJ Parkinsons Dis. 2022 Feb 21;8(1):17. doi: 10.1038/s41531-022-00277-z.
8
A critical appraisal of MAO-B inhibitors in the treatment of Parkinson's disease.MAO-B 抑制剂治疗帕金森病的关键性评价。
J Neural Transm (Vienna). 2022 Jun;129(5-6):723-736. doi: 10.1007/s00702-022-02465-w. Epub 2022 Feb 2.
9
The Evidence for Sparsentan-Mediated Inhibition of and : Possibly Unlinked to Its Antagonism of Angiotensin II or Endothelin Type a Receptor.司帕生坦介导对[具体物质1]和[具体物质2]抑制作用的证据:可能与其对血管紧张素II或A型内皮素受体的拮抗作用无关。
Biomedicines. 2021 Dec 31;10(1):86. doi: 10.3390/biomedicines10010086.
10
Characteristics of wearing-off and motor symptoms improved by safinamide adjunct therapy in patients with Parkinson's disease: A post hoc analysis of a Japanese phase 2/3 study.在帕金森病患者中,添加氨磺必利辅助治疗对改善“开-关”现象和运动症状的特点:一项日本 2/3 期研究的事后分析。
J Neurol Sci. 2022 Mar 15;434:120083. doi: 10.1016/j.jns.2021.120083. Epub 2021 Dec 11.